PLRZ - Polyrizon Ltd. Ordinary Shares

PLRZ - Polyrizon Ltd. Ordinary Shares

https://www.polyrizon-biotech.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

GlobeNewswire • 3 days, 4 hours ago • score: 0.04

Ra'anana, Israel, Sept. 12, 2025 ( GLOBE NEWSWIRE ) -- Polyrizon Ltd. ( Nasdaq: PLRZ ) ( "Polyrizon" or the "Company" ) , a biotechnology company focusing on the development of intranasal products, today announced encouraging preclinical results supporting the performance of its PL-14 Allergy ...

Polyrizon Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire • 1 month ago • score: 0.04

Ra'anana, Israel, Aug. 14, 2025 ( GLOBE NEWSWIRE ) -- Polyrizon Ltd. ( Nasdaq: PLRZ ) ( "Polyrizon" or the "Company" ) , a biotechnology company focusing on the development of intranasal products, today announced that it has received formal confirmation from the Hearings Advisor ( the "Hearings ...

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

GlobeNewswire • 1 month, 3 weeks ago • score: 0.04

Ra'anana, Israel, July 22, 2025 ( GLOBE NEWSWIRE ) -- Polyrizon Ltd. ( Nasdaq: PLRZ ) ( "Polyrizon" or the "Company" ) , a biotechnology company focusing on the development of intranasal products, today announced encouraging preclinical results supporting the performance of its PL-14 Allergy ...

Polyrizon Stock Slides After Hours After 52% Surge On Tuesday: Why It Moved - Polyrizon ( NASDAQ:PLRZ )

Benzinga • 1 month, 4 weeks ago • score: 0.04

Polyrizon Ltd PLRZ saw a dip in its stock value during after-hours trading on Wednesday. What Happened: The after-hours price of Polyrizon's stock was $0.92, marking a 12.02% dip from the previous day's closing price of $1.04. This follows a regular trading session surge of 52.47%.

Polyrizon Retains Nasdaq Listing Following Hearings Panel

GlobeNewswire • 2 months ago • score: 0.14

Raanana, Israel, July 15, 2025 ( GLOBE NEWSWIRE ) -- Polyrizon Ltd. ( Nasdaq: PLRZ ) ( the "Company" or "Polyrizon" ) , a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a notification letter from the Nasdaq ...

Polyrizon Announces Receipt of Nasdaq Delisting Notice

GlobeNewswire • 3 months, 3 weeks ago • score: 0.13

Raanana, Israel, May 23, 2025 ( GLOBE NEWSWIRE ) -- Polyrizon Ltd. ( Nasdaq: PLRZ ) ( the "Company" or "Polyrizon" ) , a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a notification letter from the Listing ...

Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform

GlobeNewswire • 3 months, 3 weeks ago • score: 0.08

The Company demonstrated strong mucoadhesion and broad surface coverage in ex vivo nasal tissue models ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company is headquartered in Ra'anana, Israel.

52W High

$1200.00

52W Low

$0.55

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

N/A

Valuation

As of 2023-12-31 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

N/A

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

N/A

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

66.89%

Institutions (25–75% balanced)

1.99%

Shares Outstanding

4,194,400

Float

823,740

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

As of 2023-12-31 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

-0.24

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

N/A

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.1931

Previous

-0.2301

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025